Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-000486-23Phase 4Completed
Phase 4 trial of fentanyl and sufentanil (4 arms), sponsored by Helsinki University Hospital. Primary endpoint: Achieved level of analgesia at 20 minutes. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-000486-23.